Related Experiment Video
Updated: Jul 16, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive
So Ra Kim1,2, Byung-Wan Lee1,2
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Ketone bodies (KBs), like beta-hydroxybutyrate (β-HB), have complex roles in metabolism. Their impact on diabetes progression and diabetic cardiomyopathy is context-dependent, requiring further research.
Area of Science:
- Metabolic biochemistry
- Cardiovascular research
- Endocrinology
Background:
- Circulating ketone bodies (KBs), especially beta-hydroxybutyrate (β-HB), function as both energy sources and signaling molecules.
- β-HB influences pathways related to oxidative stress, inflammation, and mitochondrial health.
- The precise clinical significance of circulating KBs in cardiometabolic diseases is not fully understood.
Purpose of the Study:
- To review current evidence on the role of KBs in glycemic progression and diabetic cardiomyopathy (DCM).
- To explore the conflicting findings regarding KB levels and their association with hyperglycemia and type 2 diabetes.
- To examine the divergent effects of β-HB on cardiac function and remodeling in DCM models.
Main Methods:
- Systematic review of epidemiologic and experimental studies.
- Analysis of research investigating KB levels in relation to hyperglycemia and type 2 diabetes.
- Evaluation of studies examining β-HB's effects on mitochondrial function and cardiac remodeling in DCM.
Main Results:
- Conflicting associations exist between KB levels and the development of hyperglycemia or type 2 diabetes.
- Some studies suggest elevated KBs indicate a favorable metabolic state or compensation, while others link them to worsening glycemia.
- β-HB has shown both beneficial effects (improved mitochondrial function) and detrimental effects (metabolic inflexibility) in DCM models.
Conclusions:
- The metabolic effects of β-HB are highly context-dependent.
- Factors influencing β-HB's impact include concentration, induction method of ketosis, and the individual's metabolic or disease status.
- Further research is needed to determine if β-HB is an adaptive or maladaptive metabolic signal in cardiometabolic disease.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Hyperglycemia
Type I Diabetes II: Pathophysiology
